Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 2
1995 1
1996 2
1997 3
1998 2
1999 2
2002 1
2008 1
2009 1
2011 2
2012 1
2014 1
2015 1
2016 1
2017 1
2019 1
2021 1
2022 2
2023 2
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
Cerebral Embolic Protection during TAVR.
Tiberti G. Tiberti G. N Engl J Med. 2023 Feb 16;388(7):667. doi: 10.1056/NEJMc2215783. N Engl J Med. 2023. PMID: 36791172 No abstract available.
G-CSF treatment for STEMI: final 3-year follow-up of the randomised placebo-controlled STEM-AMI trial.
Achilli F, Malafronte C, Maggiolini S, Lenatti L, Squadroni L, Gibelli G, Capogrossi MC, Dadone V, Gentile F, Bassetti B, Di Gennaro F, Camisasca P, Calchera I, Valagussa L, Colombo GI, Pompilio G; STEM-AMI trial Investigators. Achilli F, et al. Heart. 2014 Apr;100(7):574-81. doi: 10.1136/heartjnl-2013-304955. Epub 2014 Jan 10. Heart. 2014. PMID: 24415665 Clinical Trial.
Two Myocardial Infarctions and Five 8,000-m Peaks.
Savonitto S, Piatti L, Tiberti G. Savonitto S, et al. Among authors: tiberti g. Am J Cardiol. 2023 Dec 15;209:8-9. doi: 10.1016/j.amjcard.2023.09.062. Epub 2023 Oct 17. Am J Cardiol. 2023. PMID: 37856916
LombardIMA: a regional registry for coronary angioplasty in ST-elevation myocardial infarction.
Politi A, Martinoni A, Klugmann S, Zanini R, Onofri M, Guagliumi G, Fiorentini C, Lettieri C, Belli G, Piccaluga E, De Cesare N, D'Urbano M, Ettori F, Repetto A, Musumeci G, Castiglioni B, Colombo P, Passamonti E, Bramucci E, Cattaneo L, Ferrari G, Repetto S, Bartorelli A, Pirelli S, De Servi S; LombardIMA Study Group. Politi A, et al. J Cardiovasc Med (Hagerstown). 2011 Jan;12(1):43-50. doi: 10.2459/JCM.0b013e328340334d. J Cardiovasc Med (Hagerstown). 2011. PMID: 20935576
Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry.
Rigattieri S, Lettieri C, Tiberti G, Romano M, Ferlini M, Testa L, Pierini S, Ettori F, Passamonti E, Marchese A, Musumeci G, Esposito G, Tarantini G. Rigattieri S, et al. Among authors: tiberti g. J Interv Cardiol. 2022 Mar 29;2022:9609970. doi: 10.1155/2022/9609970. eCollection 2022. J Interv Cardiol. 2022. PMID: 35418809 Free PMC article.
[Role of heart rehabilitation in failure].
Tiberti G, Capucci A, Piepoli M. Tiberti G, et al. Cardiologia. 1999 Dec;44 Suppl 1(Pt 1):139-41. Cardiologia. 1999. PMID: 12497897 Review. Italian. No abstract available.
32 results